结节病药物依从性与临床结局的关联
在约翰霍普金斯结节病门诊纳入117例接受治疗的成人肺结节病患者,评估药物依从性与临床结局的关联。结果显示66%报告至少一种不依从行为,较高依从性与更好健康相关生活质量相关(P < .05),黑人参与者依从性低于白人(P < .05),依从性与医疗利用、肺功能指标无关联。
要点
- 结节病患者中66%报告至少一种药物不依从行为。
- 较高药物依从性与更好健康相关生活质量相关(P < .05)。
- 黑人参与者报告的药物依从性低于白人参与者(P < .05)。
核心结论
- 较高药物依从性与更好的健康相关生活质量相关。
- 黑人参与者报告的药物依从性低于白人参与者。
- 药物依从性与医疗利用、FVC %预计值、FEV1 %预计值或DLCO %预计值无关联。
研究设计与样本
- 观察性研究,在约翰霍普金斯结节病门诊纳入117例接受治疗的成人肺结节病患者。
- 通过问卷评估药物依从性、健康相关生活质量、医疗利用及社会人口学信息。
- 从病历中提取肺功能、病程、合并症及结节病器官受累等临床信息。
主要发现
- 117例参与者中57%为女性,55%为黑人,中位年龄57岁。
- 66%的个体报告至少一种不依从行为。
- 较高药物依从性与更好健康相关生活质量相关(P < .05)。
- 药物依从性与医疗利用的比值比、FVC %预计值、FEV1 %预计值或DLCO %预计值无关联。
- 黑人参与者报告的药物依从性低于白人参与者(P < .05)。
临床怎么用
- 药物依从性可能是改善结节病患者报告结局和健康差异的重要干预靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sarcoidosis, one of the most common interstitial lung diseases, has significant health disparities. Approximately 50% of individuals affected with sarcoidosis will undergo spontaneous remission, but those who do not undergo remission often require long-term or lifelong treatment to prevent disease progression. We sought to assess the association between medication adherence and clinical outcomes in sarcoidosis. METHODS: Adult patients in the Johns Hopkins Sarcoidosis Clinic diagnosed with pulmonary sarcoidosis on treatment were eligible for enrollment. Questionnaires were administered to assess medication adherence, health-related quality of life (HRQoL), health-care utilization, and sociodemographic information. Clinical information was abstracted from medical charts including lung function, disease duration, comorbidities, and sarcoidosis organ involvement. RESULTS: A total of 117 participants were enrolled (57% women; 55% black; median age, 57 years). Within the cohort, 66% of individuals reported at least one nonadherent behavior. Higher medication adherence was associated with better HRQoL (P < .05). There was no association between medication adherence and the odds of health-care utilization, FVC % predicted, FEV1 % predicted, or diffusion capacity of the lungs for carbon monoxide % predicted. Black participants reported lower medication adherence than white participants (P < .05). CONCLUSIONS: This is the first observational study of medication adherence in sarcoidosis. We found that higher medication adherence was associated with better HRQoL, with blacks more likely to report nonadherence. Medication adherence may be an important target to improve patient-reported outcomes and health disparities in sarcoidosis.
引用
- Sharp M, Brown T, Chen ES, et al. Association of Medication Adherence and Clinical Outcomes in Sarcoidosis. Chest. 2020. PMID: 32032588. doi:10.1016/j.chest.2020.01.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。